MASTERINVEST Kapitalanlage GmbH Takes $6.53 Million Position in Proto Labs, Inc. $PRLB

Key Points

• MASTERINVEST Kapitalanlage GmbH acquired 71,977 Proto Labs shares worth approximately $6.53 million, giving it a 0.30% stake. Institutional investors and hedge funds collectively own 84.54% of the company.
• Proto Labs exceeded quarterly expectations, reporting $0.60 EPS versus a $0.53 estimate and revenue of $149.34 million, up 10.5% year over year. The company guided for third-quarter EPS of $0.56–$0.64.
• Analyst sentiment remains positive, with the stock carrying an average “Buy” rating and an average price target of $89.00; shares recently opened at $80.20.

MASTERINVEST Kapitalanlage GmbH purchased a new position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 71,977 shares of the industrial products company's stock, valued at approximately $6,531,000. MASTERINVEST Kapitalanlage GmbH owned approximately 0.30% of Proto Labs at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of PRLB. Group One Trading LLC acquired a new position in Proto Labs during the fourth quarter worth $25,000. NewEdge Advisors LLC grew its holdings in Proto Labs by 7,380.0% in the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 738 shares during the last quarter. NBC Securities Inc. purchased a new position in shares of Proto Labs in the fourth quarter valued at $46,000. USA Financial Formulas purchased a new position in shares of Proto Labs in the first quarter valued at $52,000. Finally, Modus Advisors LLC acquired a new position in shares of Proto Labs during the 4th quarter worth $57,000. Institutional investors and hedge funds own 84.54% of the company's stock.

Insiders Place Their Bets

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the firm's stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director directly owned 32,505 shares of the company's stock, valued at approximately $2,511,986.40. This trade represents a 5.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company's stock.

Proto Labs Stock Performance

Shares of PRLB opened at $80.20 on Friday. Proto Labs, Inc. has a fifty-two week low of $45.10 and a fifty-two week high of $93.00. The company has a market capitalization of $1.92 billion, a PE ratio of 64.16 and a beta of 1.40. The stock has a fifty day moving average of $80.46 and a two-hundred day moving average of $70.91.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.07. The business had revenue of $149.34 million for the quarter, compared to analysts' expectations of $144.53 million. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The business's revenue was up 10.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, equities research analysts forecast that Proto Labs, Inc. will post 1.46 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Zacks Research upgraded shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 6th. Weiss Ratings downgraded shares of Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday, August 18th. Wall Street Zen cut shares of Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. Benchmark upped their price target on shares of Proto Labs from $70.00 to $91.00 and gave the company a "buy" rating in a report on Thursday, July 2nd. Finally, Needham & Company LLC upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 price target on the stock in a research report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $89.00.

Proto Labs Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source